Predictive risk factors for coronary artery abnormalities in Kawasaki disease
- 11 October 2006
- journal article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 166 (5) , 421-425
- https://doi.org/10.1007/s00431-006-0251-8
Abstract
Clinical characteristics to predict the development of coronary artery abnormalities (CAA) in Kawasaki disease (KD) were assessed by reviewing medical records of patients diagnosed with KD at Korea University Medical Center from March 2001 to February 2005. Of the 285 patients diagnosed with KD, 19 developed CAA (6.7%). Compared with the CAA(−) group, the CAA(+) group had a longer duration of fever after intravenous gamma-globulin (IVGG) injection (2.4±2.9 vs. 1.5±1.2 days, p=0.008) and higher C-reactive protein (CRP)(12.3±7.8 vs. 8.7±7.1 mg/dL, p=0.038). In particular, the CAA(+) group tended to have more than 7 days of fever before IVGG and more than 3 days of fever after IVGG (26.3 vs. 5.3%, pp=0.002). When the IVGG responsiveness was defined by the presence of defervescence within 3 days after IVGG, IVGG-non-responders showed a higher incidence of CAA (22.7 vs. 5.3%, p=0.002). Non-responders had a longer duration of fever after IVGG (5.5±1.9 vs. 1.2±0.6 days, pp=0.0293). Conclusively, the most important predictor of CAA in KD is total duration of fever longer than 8 days. Early identification of IVGG non-responders and active therapeutic intervention for fever in KD cases might decrease the incidence of CAA.Keywords
This publication has 27 references indexed in Scilit:
- Risk factors associated with the need for additional intravenous gamma-globulin therapy for Kawasaki diseaseActa Paediatrica, 2006
- Diagnosis, Treatment, and Long-Term Management of Kawasaki DiseaseCirculation, 2004
- Coronary risk factors in Kawasaki disease treated with additional gammaglobulinArchives of Disease in Childhood, 2004
- Early intravenous gamma-globulin treatment for kawasaki disease: The nationwide surveys in JapanThe Journal of Pediatrics, 2004
- Advances in Kawasaki diseaseEuropean Journal of Pediatrics, 2004
- Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki diseasePediatrics International, 2004
- A multicenter collaborative study on the risk factors of cardiac sequelae due to Kawasaki disease: a one‐year follow‐up studyActa Paediatrica, 2000
- Intravenous gamma-globulin treatment and retreatment in Kawasaki diseaseThe Pediatric Infectious Disease Journal, 1998
- Intravenous γ‐Globulin Treatment in Kawasaki DiseasePediatrics International, 1991
- Regression of aneurysms in Kawasaki disease: A pathological studyThe Journal of Pediatrics, 1982